US Vaccine Market Extracting Vigor from Flu Vaccines

Released on: December 27, 2007, 11:42 pm

Press Release Author: Shushmul Maheshwari

Industry: Media

Press Release Summary: The US vaccine market is thriving with life. As per RNCOS
report, the market is likely to go strong in future due to various factors,
including tangible growth in flu vaccines.

Press Release Body: According to a new research report released recently by the
leading market research firm RNCOS "Global Vaccine Market Outlook (2007-2010)", the
global vaccine market, characterized by sluggish growth, is seeing an upturn due to
launch of new paediatric vaccines and the booming influenza vaccine markets in the
US and Europe. It has identified the US as the largest vaccine market globally
followed by Europe. During 2003 to 2006, as the report says, the US vaccine market
grew at a projected CAGR of 9.3% and is anticipated to maintain the same rate till
2008 with the launch of several developmental vaccines in the market.

However, despite this sound growth rate, the number of vaccine makers has slipped
down to a few in the US from the past three decades. The RNCOS research has tried to
find out the reasons behind this rather surprising trend observed in the US market.

Also, flu vaccine is considered very important in the US. Earlier in September 2007,
the US Food and Drug Administration (FDA) approved an additional seasonal flu
vaccine to immunize adults (18 years and above) against type A and B flu viruses.
The report has thoroughly studied the market to come up with the factors that are
making flu vaccines so vital for the US vaccine market. It also highlights the
measures and actions being taken by the US government to combat the rising problem
of influenza infection.

The RNCOS study has analyzed the market to look for various vaccines in the
development stages and for which specific diseases they are meant for. It has also
studied the various vaccine groups to define the ones that will record fastest
growth in the US human vaccines market.

The US vaccine market is just one of the many markets discussed in the descriptive
"Global Vaccine Market Outlook (2007-2010)". The other markets include Japan, China,
Brazil, and India. It briefly discusses the regulatory framework, intellectual
property rights, market performance of various vaccine segments and vaccines, and
gives an insight into the forces, opportunities and challenges for the global
vaccine market. After rationally evaluating the global market, RNCOS has presented a
future forecast of the market and its various segments.

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.

For more information visit:
Current Industry News:

Web Site:

Contact Details: RNCOS E-Services Pvt. Ltd.
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...